Savara Inc.

SVRA
Buy Open
Signal type
Buy
Status
Open
Open Price
$6.24
Stop Loss
$5.78
Performance
-2.72%
Days Open
1

Signal Setup

Signal Type Buy
Status Open
Open Date Apr 14, 2026
Open Price $6.24
Stop Loss $5.78
Timespan Day

Company Profile

Name Savara Inc.
Ticker SVRA
Market Cap $394.07M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $6.07
List Date Nov 18, 1996
Description

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.